The Senate Special Committee on Aging today concluded a two-part hearing on the impact of rising prescription drug costs on seniors and potential policy solutions.
Stacie Dusetzina, an associate professor of health policy at Vanderbilt University Medical Center in Nashville, Tenn., who participated on a National Academy of Medicine committee that issued a 2017 report on strategies for making prescription drugs more affordable, urged the Senate committee to focus on three key goals: ensuring that patients can access high-value drugs at reasonable out-of-pocket costs; removing incentives for high list prices and price increases; and rewarding true innovation by pharmaceutical companies by paying for value.

Also testifying at the hearing were representatives from Consumer Reports, Point-of-Care Partners and Horvath Health Policy.
The House Ways and Means Health Subcommittee also held a hearing today focused on promoting competition to lower Medicare drug prices. Witnesses included representatives from the Institute for Innovation Law at the University of California Hastings School of Law; Program on Regulation, Therapeutics and Law at Harvard Medical School; Global Health Justice Partnership at Yale Law School; Families USA; and American Action Forum.
AHA has recommended a number of policy solutions to restrain drug prices, from addressing anticompetitive actions by brand-name drug manufacturers to speeding up generic drug approvals and passing the CREATES Act.

Related News Articles

About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…
Legislative proposals for a Medicare public option could negatively affect patient access to care and significantly reduce payments to hospitals, AHA Executive…
The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2017 data.
The House Energy and Commerce Health Subcommittee today held a hearing to discuss seven bills aimed at increasing competition in the prescription drug market…
Eight in 10 U.S. adults say prescription drug costs are “unreasonable,” and one in four say their prescription medicines are difficult to afford, according to…
Patients and their providers rely on these prescription drugs for treating injury and managing illness. Yet the drug companies and their shareholders have been…